We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VNDA market cap is 271.86M. The company's latest EPS is USD 0.0436 and P/E is 108.49.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 65.32M | 64.48M | 62.5M | 46.06M | 38.82M |
| Operating Income | 3.91M | 6.63M | 2M | -2.87M | -6M |
| Net Income | 3.27M | 6.86M | 3.25M | 1.52M | 137k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 227.19M | 248.17M | 268.68M | 254.38M | 192.64M |
| Operating Income | 22.81M | 27.24M | 42.17M | 6.33M | -13.95M |
| Net Income | 115.55M | 23.34M | 33.15M | 6.28M | 2.51M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 621.79M | 634.25M | 644.53M | 641.68M | 641.61M |
| Total Liabilities | 106.13M | 107.05M | 108.79M | 101.78M | 98.51M |
| Total Equity | 515.66M | 527.2M | 535.74M | 539.9M | 543.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 483.75M | 533.46M | 593.79M | 634.25M | 648.44M |
| Total Liabilities | 72.8M | 80.19M | 88.86M | 107.05M | 103.53M |
| Total Equity | 410.95M | 453.27M | 504.93M | 527.2M | 544.91M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 22.57M | 31.98M | 31.8M | 18.58M | 16.53M |
| Investing | -25.5M | 49.93M | 187.29M | -3.6M | 31.73M |
| Financing | 129k | 734k | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 45.95M | 51.78M | 64.21M | 31.98M | 12.8M |
| Investing | -68.31M | -41.5M | -76.7M | 49.93M | -12.06M |
| Financing | 6.26M | 5.63M | 3.55M | 734k | N/A |
| Market Cap | 271.86M |
| Price to Earnings Ratio | 108.49 |
| Price to Sales Ratio | 1.41 |
| Price to Cash Ratio | 2 |
| Price to Book Ratio | 0.5 |
| Dividend Yield | - |
| Shares Outstanding | 57.54M |
| Average Volume (1 week) | 1.08M |
| Average Volume (1 Month) | 5.24M |
| 52 Week Change | -23.42% |
| 52 Week High | 7.00 |
| 52 Week Low | 3.295 |
| Spread (Intraday) | 0.01 (0.21%) |
| Company Name | Vanda Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vandapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
